Condition
Lymphoma, Lymphoblastic clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Lymphoma, Lymphoblastic clinical trials that are recruiting, at sites in 3 countries (most in Australia (1), United States (1), Switzerland (1)). By phase: Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
CTD402 for relapsed or refractory T-ALL and T-LBL
This trial will test whether a single infusion of CTD402 UCART can be safe and shrink cancer in people age 12 and older with relapsed or refractory T‑cell acute lymphoblastic leukemia or lymphoblastic lymphoma.
-
Assessing adrenal function in children with leukemia after glucocorticoid treatment
This study is trying to see how glucocorticoid treatment affects the adrenal function in children with leukemia to better understand and manage any potential hormone problems they might have after treatment.
Related topics
Quick answers
How many Lymphoma, Lymphoblastic clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (1 trial), United States (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.